Condition
Nasal Surgical Procedures
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (2)
P 3 (1)
Trial Status
Completed2
Enrolling By Invitation1
Not Yet Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04194216Phase 3Enrolling By Invitation
Antibiotic Prophylaxis in Rhinoplasty
NCT05273060Not ApplicableCompletedPrimary
Regenerative Medicine Approach to Nasal Reconstruction
NCT06885801Phase 2Not Yet Recruiting
Evaluation of a Novel Nasal Conformer in Pediatric Patients
NCT02822781Completed
Chronic Rhinosinusitis Classification Proposal
NCT02062996Phase 2Withdrawn
Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption
Showing all 5 trials